The Garvan Institute is a national and international leader in medical research.

We have a strong history of both scientific and commercial collaboration — some of our discoveries have led to new companies like G2 Therapies and Solvanix.

Our approach to partnering is flexible and commercially-focused. We recognise the essential role industry plays in pharmaceutical and diagnostic R&D. This helps us to achieve the goal of preventing and curing human disease.

We are able to provide access to our world-leading expertise and facilities and will work with industry to further our translational mission. This can be realised through:

• engaging in collaborative R&D projects
• performing contract research
• licensing our Intellectual property to entrepreneurs and to industry partners
• helping to found and attract investment to spin-off companies developing new products based on our unique contributions.